- Home
- ALTS vs RAPT Comparison
ALTS vs RAPT Comparison
Compare ALTS & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTS
- RAPT
- Stock Information
- Founded
- ALTS 1976
- RAPT 2015
- Country
- ALTS United States
- RAPT United States
- Employees
- ALTS N/A
- RAPT N/A
- Industry
- ALTS
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- ALTS
- RAPT Health Care
- Exchange
- ALTS NYSE
- RAPT Nasdaq
- Market Cap
- ALTS 109.1M
- RAPT 117.5M
- IPO Year
- ALTS N/A
- RAPT 2019
- Fundamental
- Price
- ALTS $9.31
- RAPT $0.89
- Analyst Decision
- ALTS
- RAPT Buy
- Analyst Count
- ALTS 0
- RAPT 5
- Target Price
- ALTS N/A
- RAPT $5.25
- AVG Volume (30 Days)
- ALTS 251.8K
- RAPT 1.1M
- Earning Date
- ALTS 05-13-2025
- RAPT 05-08-2025
- Dividend Yield
- ALTS N/A
- RAPT N/A
- EPS Growth
- ALTS N/A
- RAPT N/A
- EPS
- ALTS N/A
- RAPT N/A
- Revenue
- ALTS $18,046,000.00
- RAPT N/A
- Revenue This Year
- ALTS N/A
- RAPT N/A
- Revenue Next Year
- ALTS N/A
- RAPT N/A
- P/E Ratio
- ALTS N/A
- RAPT N/A
- Revenue Growth
- ALTS N/A
- RAPT N/A
- 52 Week Low
- ALTS $1.29
- RAPT $0.71
- 52 Week High
- ALTS $10.40
- RAPT $4.60
- Technical
- Relative Strength Index (RSI)
- ALTS 81.41
- RAPT 48.13
- Support Level
- ALTS $6.34
- RAPT $0.81
- Resistance Level
- ALTS $9.84
- RAPT $1.27
- Average True Range (ATR)
- ALTS 0.89
- RAPT 0.14
- MACD
- ALTS 0.30
- RAPT 0.01
- Stochastic Oscillator
- ALTS 95.23
- RAPT 31.55
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.